The new Versa HD system at ARC's St. Andrew's Hospital location will enable clinicians to commission several advanced radiotherapy techniques for a range of cancer conditions, according to ARC radiation oncologist Marcus Dreosti, MD.
"Versa HD really changes how we can treat cancer in so many ways," he says. "It will expand the range of cancers that can be successfully managed with radiation and shorten treatment times, which reduces the impact on patients' quality of life. We are able to be so precise in targeting tumors that in certain clinical applications we can deliver higher doses in fewer treatments and achieve better outcomes with fewer complications."
Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Established in 1985, ARC is the largest provider of radiotherapy services in South Australia with centers in Adelaide City, Bedford Park, Kurralta Park and Elizabeth Vale.
Nelune Comprehensive Cancer Centre
Prince of Wales Hospital's Nelune Comprehensive Cancer Centre (Sydney, NSW) recently replaced two Siemens linear accelerators with an Elekta Infinity™ system and a Versa HD system, which join an Elekta Axesse™ system the center purchased in 2009. Elekta Infinity is now clinically operational, and Versa HD will be commissioned by the New Year.
"With Versa HD, we're looking forward to shorter treatment times, particularly for simpler treatments, such as prostate cases, and better dose distributions for conventional IMRT cases and for VMAT once we start using that technique," says Michael Jackson, MD, radiation oncology center director.
Versa HD will be a welcome addition to Nelune's intra- and extra-cranial SBRT program, he adds.
"We will use the system mainly for cancers in the brain, lung, liver, pancreas and spine, in which the ultra-conformal beam shaping capabilities of Versa HD are especially important."
For more information, visit www.VersaHD.com.
Versa HD is not for sale or distribution in all markets.
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Kris Walmsley, Corporate Communications Manager, Elekta AB
Tel: +46 70 537 9545, e-mail: kris.walmsley@elekta.com
Time zone: CET: Central European Time
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.
Back to HCB News
